Clinical Trial

Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-30; most recent amendment 2025-01-21.
Status change: Not Yet Recruiting → Recruiting 2023-09-26
Trial Details
NCT Number NCT05936346
Lead Sponsor IBSA Farmaceutici Italia Srl
Conditions Aging
Enrollment 50 participants
Start Date 2023-07-17
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-23